Share Price and Basic Stock Data
Last Updated: October 18, 2025, 7:01 pm
| PEG Ratio | 0.35 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Ugro Capital Ltd operates in the finance and investments sector, demonstrating significant growth in revenue over recent years. For the fiscal year ending March 2023, the company reported revenue of ₹684 Cr, marking a substantial increase from ₹312 Cr in March 2022. Revenue continued its upward trajectory with quarterly figures reflecting a consistent month-on-month growth, reaching ₹245 Cr in September 2023 and ₹268 Cr in December 2023. This positive trend in revenue can be attributed to a diversified lending portfolio and a focus on underserved segments of the market. The company’s revenue from operations per share stood at ₹151.82 for March 2025, an increase from ₹94.70 in March 2023, showcasing its ability to scale operations effectively. Ugro’s financing profit also increased notably, indicating enhanced margins and operational efficiency, with a financing margin of 15% reported in March 2025.
Profitability and Efficiency Metrics
Ugro Capital’s profitability metrics have shown a commendable performance, with a net profit of ₹144 Cr reported for the fiscal year ending March 2025, significantly up from ₹40 Cr in March 2023. The company’s earnings per share (EPS) rose to ₹15.68, reflecting a healthy growth trajectory. The return on equity (ROE) was reported at 8.26%, while the return on capital employed (ROCE) stood at 11.0%, indicating efficient utilization of equity and capital. The interest coverage ratio (ICR) of 1.40x suggests that Ugro can comfortably meet its interest obligations, providing a cushion against potential financial distress. Additionally, the gross non-performing asset (NPA) ratio was relatively controlled, reported at 2.00% in December 2023, which is crucial for maintaining profitability in the lending business. Overall, these figures reflect a robust operational framework, positioning Ugro favorably against its peers in the finance sector.
Balance Sheet Strength and Financial Ratios
The balance sheet of Ugro Capital indicates a growing asset base, with total assets reported at ₹9,168 Cr for March 2025, up from ₹4,306 Cr in March 2023. Reserves have also seen significant growth, standing at ₹1,954 Cr, which is a critical buffer for future expansions and risk management. The company has leveraged its equity effectively, with a total debt-to-equity ratio of 2.39, which suggests a higher reliance on borrowed funds. However, this is offset by the high interest coverage ratio of 1.40, indicating that Ugro can manage its debt service commitments comfortably. The price-to-book value ratio stands at 0.73x, suggesting that the stock may be undervalued compared to its book value, which could attract value-focused investors. Overall, Ugro’s balance sheet reflects a mix of growth and leverage that warrants careful monitoring.
Shareholding Pattern and Investor Confidence
Ugro Capital’s shareholding structure reflects a diversified investor base, with foreign institutional investors (FIIs) holding 29.32% of the shares as of March 2025, a significant increase from 7.47% in September 2022. This trend indicates growing confidence among institutional investors in Ugro’s business model and growth prospects. The promoter holding has remained stable at 2.25%, while domestic institutional investors (DIIs) have seen a decline to 1.62%. The public shareholding stood at 64.69%, demonstrating a broad base of retail investors. The number of shareholders increased to 42,370 by June 2025, suggesting that interest in the company is growing. This diversified ownership structure can enhance liquidity and stability in Ugro’s stock, reflecting a positive sentiment in the market.
Outlook, Risks, and Final Insight
If Ugro Capital maintains its revenue growth trajectory and continues to manage its NPAs effectively, it could solidify its position in the competitive finance sector. However, the company’s reliance on debt financing poses risks, particularly in a rising interest rate environment, which could strain profitability. Additionally, the declining trend in DII participation could signal caution among domestic investors. The firm must also navigate potential regulatory changes in the financial sector that could impact lending practices. Overall, while Ugro Capital demonstrates robust growth and operational efficiency, vigilance in managing risks and maintaining investor confidence will be critical for its sustained success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ugro Capital Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 12.1 Cr. | 41.3 | 67.7/36.4 | 43.2 | 43.5 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,445 Cr. | 308 | 495/280 | 15.8 | 102 | 0.32 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 37.3 Cr. | 0.53 | 2.42/0.46 | 3.62 | 0.02 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.49 Cr. | 9.08 | 12.7/8.25 | 10.3 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 24.4 Cr. | 47.6 | 72.0/47.6 | 20.6 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 6,763.07 Cr | 1,429.69 | 132.51 | 3,769.18 | 0.31% | 21.70% | 14.20% | 7.28 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 117 | 149 | 182 | 209 | 213 | 245 | 268 | 322 | 291 | 330 | 371 | 403 | 414 |
| Interest | 53 | 69 | 82 | 90 | 93 | 105 | 117 | 128 | 136 | 143 | 167 | 181 | 205 |
| Expenses | 57 | 64 | 81 | 87 | 82 | 99 | 107 | 136 | 113 | 139 | 152 | 161 | 156 |
| Financing Profit | 7 | 16 | 19 | 32 | 38 | 41 | 44 | 58 | 43 | 48 | 52 | 61 | 53 |
| Financing Margin % | 6% | 11% | 11% | 15% | 18% | 17% | 16% | 18% | 15% | 15% | 14% | 15% | 13% |
| Other Income | 5 | 6 | 8 | 8 | 5 | 9 | 12 | 8 | 10 | 13 | 14 | 9 | 8 |
| Depreciation | 2 | 5 | 5 | 6 | 8 | 9 | 9 | 10 | 10 | 11 | 12 | 13 | 13 |
| Profit before tax | 10 | 18 | 22 | 34 | 36 | 41 | 46 | 56 | 43 | 50 | 53 | 57 | 48 |
| Tax % | 29% | 70% | 41% | 58% | 29% | 29% | 30% | 42% | 29% | 29% | 29% | 29% | 29% |
| Net Profit | 7 | 5 | 13 | 14 | 25 | 29 | 33 | 33 | 30 | 36 | 38 | 41 | 34 |
| EPS in Rs | 0.82 | 0.59 | 1.47 | 1.57 | 2.16 | 2.47 | 2.78 | 2.78 | 2.58 | 3.02 | 3.18 | 3.44 | 2.92 |
| Gross NPA % | 1.70% | 1.70% | 1.70% | 2.46% | 1.80% | 1.90% | 2.00% | 2.00% | 2.00% | 2.10% | 2.10% | 2.30% | |
| Net NPA % | 1.20% | 1.20% | 1.10% | 1.31% | 1.00% | 1.10% | 1.10% | 1.10% | 1.20% | 1.30% | 1.50% | 1.60% |
Last Updated: August 20, 2025, 1:55 am
Below is a detailed analysis of the quarterly data for Ugro Capital Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Interest, as of Jun 2025, the value is 205.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 181.00 Cr. (Mar 2025) to 205.00 Cr., marking an increase of 24.00 Cr..
- For Expenses, as of Jun 2025, the value is 156.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 161.00 Cr. (Mar 2025) to 156.00 Cr., marking a decrease of 5.00 Cr..
- For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 9.00 Cr..
- For Tax %, as of Jun 2025, the value is 29.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00%.
- For Net Profit, as of Jun 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.92. The value appears to be declining and may need further review. It has decreased from 3.44 (Mar 2025) to 2.92, marking a decrease of 0.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:13 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 2 | 4 | 2 | 4 | 44 | 105 | 153 | 312 | 684 | 1,082 | 1,396 | 1,518 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 14 | 45 | 137 | 293 | 443 | 628 | 697 |
| Expenses | 1 | 1 | 0 | 0 | 0 | 36 | 81 | 85 | 142 | 289 | 425 | 565 | 607 |
| Financing Profit | 5 | 2 | 3 | 2 | 3 | 7 | 11 | 24 | 33 | 101 | 214 | 204 | 214 |
| Financing Margin % | 86% | 76% | 92% | 86% | 91% | 16% | 10% | 16% | 10% | 15% | 20% | 15% | 14% |
| Other Income | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 0 | 0 | 0 | 0 | 46 | 44 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 12 | 12 | 18 | 35 | 46 | 49 |
| Profit before tax | 5 | 2 | 3 | 2 | 3 | 2 | 3 | 12 | 20 | 84 | 179 | 203 | 208 |
| Tax % | 30% | 7% | 14% | 2% | 8% | -155% | -488% | -137% | 28% | 53% | 33% | 29% | |
| Net Profit | 4 | 2 | 3 | 2 | 3 | 4 | 20 | 29 | 15 | 40 | 119 | 144 | 148 |
| EPS in Rs | 6.41 | 2.83 | 5.07 | 3.34 | 5.05 | 1.34 | 2.19 | 3.22 | 1.63 | 4.46 | 10.17 | 12.22 | 12.56 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 50.00% | -33.33% | 50.00% | 33.33% | 400.00% | 45.00% | -48.28% | 166.67% | 197.50% | 21.01% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -83.33% | 83.33% | -16.67% | 366.67% | -355.00% | -93.28% | 214.94% | 30.83% | -176.49% |
Ugro Capital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 89% |
| 5 Years: | 68% |
| 3 Years: | 65% |
| TTM: | 35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 56% |
| 5 Years: | 49% |
| 3 Years: | 115% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 14% |
| 3 Years: | -2% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 6% |
| 3 Years: | 8% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: May 13, 2025, 2:31 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 23 | 71 | 71 | 71 | 69 | 92 | 92 |
| Reserves | 23 | 25 | 27 | 29 | 32 | 796 | 851 | 882 | 896 | 915 | 1,347 | 1,954 |
| Borrowing | 0 | 0 | 0 | 0 | 0 | 24 | 255 | 766 | 1,802 | 3,149 | 4,653 | 6,904 |
| Other Liabilities | 1 | 0 | 0 | 0 | 0 | 26 | 36 | 37 | 86 | 173 | 188 | 218 |
| Total Liabilities | 28 | 30 | 32 | 34 | 37 | 868 | 1,212 | 1,755 | 2,855 | 4,306 | 6,280 | 9,168 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 20 | 38 | 36 | 56 | 85 | 130 | 168 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 11 | 1 | 4 | 6 | 14 | 0 | 0 |
| Investments | 26 | 15 | 25 | 26 | 36 | 107 | 73 | 55 | 69 | 60 | 59 | 103 |
| Other Assets | 3 | 14 | 8 | 8 | 1 | 731 | 1,101 | 1,659 | 2,724 | 4,146 | 6,091 | 8,897 |
| Total Assets | 28 | 30 | 32 | 34 | 37 | 868 | 1,212 | 1,755 | 2,855 | 4,306 | 6,280 | 9,168 |
Below is a detailed analysis of the balance sheet data for Ugro Capital Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 92.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 92.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,954.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,347.00 Cr. (Mar 2024) to 1,954.00 Cr., marking an increase of 607.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 218.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 188.00 Cr. (Mar 2024) to 218.00 Cr., marking an increase of 30.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 9,168.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,280.00 Cr. (Mar 2024) to 9,168.00 Cr., marking an increase of 2,888.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 168.00 Cr.. The value appears strong and on an upward trend. It has increased from 130.00 Cr. (Mar 2024) to 168.00 Cr., marking an increase of 38.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 103.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Mar 2024) to 103.00 Cr., marking an increase of 44.00 Cr..
- For Other Assets, as of Mar 2025, the value is 8,897.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,091.00 Cr. (Mar 2024) to 8,897.00 Cr., marking an increase of 2,806.00 Cr..
- For Total Assets, as of Mar 2025, the value is 9,168.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,280.00 Cr. (Mar 2024) to 9,168.00 Cr., marking an increase of 2,888.00 Cr..
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 12.00 | -174.00 | -681.00 | 141.00 | 286.00 | 421.00 | 559.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | 15% | 6% | 10% | 6% | 8% | 1% | 2% | 3% | 2% | 4% | 10% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.68 | 13.39 | 5.69 | 2.06 | 4.07 |
| Diluted EPS (Rs.) | 14.71 | 13.20 | 5.66 | 2.05 | 4.07 |
| Cash EPS (Rs.) | 20.70 | 16.89 | 8.28 | 3.81 | 5.74 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 222.57 | 157.04 | 141.95 | 136.99 | 135.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 222.57 | 157.04 | 141.95 | 136.99 | 135.04 |
| Revenue From Operations / Share (Rs.) | 151.82 | 114.42 | 94.70 | 43.55 | 21.24 |
| PBDIT / Share (Rs.) | 95.41 | 71.73 | 56.94 | 24.08 | 9.70 |
| PBIT / Share (Rs.) | 90.37 | 67.88 | 54.40 | 22.33 | 8.04 |
| PBT / Share (Rs.) | 22.09 | 19.52 | 12.09 | 2.86 | 1.72 |
| Net Profit / Share (Rs.) | 15.65 | 13.03 | 5.74 | 2.06 | 4.07 |
| PBDIT Margin (%) | 62.84 | 62.69 | 60.13 | 55.29 | 45.67 |
| PBIT Margin (%) | 59.52 | 59.32 | 57.44 | 51.27 | 37.84 |
| PBT Margin (%) | 14.55 | 17.05 | 12.76 | 6.56 | 8.09 |
| Net Profit Margin (%) | 10.31 | 11.38 | 6.05 | 4.73 | 19.17 |
| Return on Networth / Equity (%) | 7.03 | 8.29 | 4.04 | 1.50 | 3.01 |
| Return on Capital Employeed (%) | 38.12 | 20.96 | 17.06 | 9.25 | 4.50 |
| Return On Assets (%) | 1.56 | 1.90 | 0.92 | 0.50 | 1.64 |
| Long Term Debt / Equity (X) | 0.00 | 0.99 | 1.16 | 0.72 | 0.31 |
| Total Debt / Equity (X) | 3.37 | 3.24 | 3.20 | 1.86 | 0.80 |
| Asset Turnover Ratio (%) | 0.18 | 0.19 | 0.18 | 0.13 | 0.10 |
| Current Ratio (X) | 1.27 | 1.83 | 1.97 | 2.36 | 3.36 |
| Quick Ratio (X) | 1.27 | 1.83 | 1.97 | 2.36 | 3.36 |
| Interest Coverage Ratio (X) | 1.40 | 1.48 | 1.35 | 1.24 | 1.54 |
| Interest Coverage Ratio (Post Tax) (X) | 1.23 | 1.27 | 1.14 | 1.11 | 1.64 |
| Enterprise Value (Cr.) | 7869.00 | 6209.26 | 3942.28 | 2792.18 | 1301.28 |
| EV / Net Operating Revenue (X) | 5.64 | 5.92 | 6.01 | 9.09 | 8.69 |
| EV / EBITDA (X) | 8.97 | 9.45 | 9.99 | 16.43 | 19.02 |
| MarketCap / Net Operating Revenue (X) | 1.08 | 1.92 | 1.53 | 3.84 | 5.68 |
| Price / BV (X) | 0.73 | 1.40 | 1.02 | 1.22 | 0.89 |
| Price / Net Operating Revenue (X) | 1.08 | 1.92 | 1.53 | 3.84 | 5.68 |
| EarningsYield | 0.09 | 0.05 | 0.03 | 0.01 | 0.03 |
After reviewing the key financial ratios for Ugro Capital Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.68. This value is within the healthy range. It has increased from 13.39 (Mar 24) to 15.68, marking an increase of 2.29.
- For Diluted EPS (Rs.), as of Mar 25, the value is 14.71. This value is within the healthy range. It has increased from 13.20 (Mar 24) to 14.71, marking an increase of 1.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 20.70. This value is within the healthy range. It has increased from 16.89 (Mar 24) to 20.70, marking an increase of 3.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.57. It has increased from 157.04 (Mar 24) to 222.57, marking an increase of 65.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.57. It has increased from 157.04 (Mar 24) to 222.57, marking an increase of 65.53.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 151.82. It has increased from 114.42 (Mar 24) to 151.82, marking an increase of 37.40.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 95.41. This value is within the healthy range. It has increased from 71.73 (Mar 24) to 95.41, marking an increase of 23.68.
- For PBIT / Share (Rs.), as of Mar 25, the value is 90.37. This value is within the healthy range. It has increased from 67.88 (Mar 24) to 90.37, marking an increase of 22.49.
- For PBT / Share (Rs.), as of Mar 25, the value is 22.09. This value is within the healthy range. It has increased from 19.52 (Mar 24) to 22.09, marking an increase of 2.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 15.65. This value is within the healthy range. It has increased from 13.03 (Mar 24) to 15.65, marking an increase of 2.62.
- For PBDIT Margin (%), as of Mar 25, the value is 62.84. This value is within the healthy range. It has increased from 62.69 (Mar 24) to 62.84, marking an increase of 0.15.
- For PBIT Margin (%), as of Mar 25, the value is 59.52. This value exceeds the healthy maximum of 20. It has increased from 59.32 (Mar 24) to 59.52, marking an increase of 0.20.
- For PBT Margin (%), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 17.05 (Mar 24) to 14.55, marking a decrease of 2.50.
- For Net Profit Margin (%), as of Mar 25, the value is 10.31. This value exceeds the healthy maximum of 10. It has decreased from 11.38 (Mar 24) to 10.31, marking a decrease of 1.07.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 15. It has decreased from 8.29 (Mar 24) to 7.03, marking a decrease of 1.26.
- For Return on Capital Employeed (%), as of Mar 25, the value is 38.12. This value is within the healthy range. It has increased from 20.96 (Mar 24) to 38.12, marking an increase of 17.16.
- For Return On Assets (%), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has decreased from 1.90 (Mar 24) to 1.56, marking a decrease of 0.34.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.99 (Mar 24) to 0.00, marking a decrease of 0.99.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 1. It has increased from 3.24 (Mar 24) to 3.37, marking an increase of 0.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.18. It has decreased from 0.19 (Mar 24) to 0.18, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 1.5. It has decreased from 1.83 (Mar 24) to 1.27, marking a decrease of 0.56.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has decreased from 1.83 (Mar 24) to 1.27, marking a decrease of 0.56.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 3. It has decreased from 1.48 (Mar 24) to 1.40, marking a decrease of 0.08.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 3. It has decreased from 1.27 (Mar 24) to 1.23, marking a decrease of 0.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,869.00. It has increased from 6,209.26 (Mar 24) to 7,869.00, marking an increase of 1,659.74.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.64. This value exceeds the healthy maximum of 3. It has decreased from 5.92 (Mar 24) to 5.64, marking a decrease of 0.28.
- For EV / EBITDA (X), as of Mar 25, the value is 8.97. This value is within the healthy range. It has decreased from 9.45 (Mar 24) to 8.97, marking a decrease of 0.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.08, marking a decrease of 0.84.
- For Price / BV (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 1.40 (Mar 24) to 0.73, marking a decrease of 0.67.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.08, marking a decrease of 0.84.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.09, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ugro Capital Ltd:
- Net Profit Margin: 10.31%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 38.12% (Industry Average ROCE: 21.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.03% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.23
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17.7 (Industry average Stock P/E: 132.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.37
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.31%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | Equinox Business Park, Mumbai Maharashtra 400070 | cs@ugrocapital.com http://www.ugrocapital.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Satyananda Mishra | Non Exe.Chairman&Ind.Director |
| Mr. Shachindra Nath | Vice Chairman & Mng.Director |
| Mr. Karuppasamy Singam | Independent Director |
| Ms. Tabassum Abdulla Inamdar | Independent Director |
| Mr. Karnam Sekar | Independent Director |
| Mr. Hemant Bhargava | Independent Director |
| Mr. Rajeev K Agarwal | Independent Director |
| Mr. Suresh Eshwara Prabhala | Non Exe. & Nominee Director |
| Mr. Rohit Goyal | Non Exe. & Nominee Director |
| Mr. Chetan Gupta | Non Exe. & Nominee Director |
FAQ
What is the intrinsic value of Ugro Capital Ltd?
Ugro Capital Ltd's intrinsic value (as of 19 October 2025) is 207.58 which is 15.32% higher the current market price of 180.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 2,615 Cr. market cap, FY2025-2026 high/low of 255/142, reserves of ₹1,954 Cr, and liabilities of 9,168 Cr.
What is the Market Cap of Ugro Capital Ltd?
The Market Cap of Ugro Capital Ltd is 2,615 Cr..
What is the current Stock Price of Ugro Capital Ltd as on 19 October 2025?
The current stock price of Ugro Capital Ltd as on 19 October 2025 is 180.
What is the High / Low of Ugro Capital Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ugro Capital Ltd stocks is 255/142.
What is the Stock P/E of Ugro Capital Ltd?
The Stock P/E of Ugro Capital Ltd is 17.7.
What is the Book Value of Ugro Capital Ltd?
The Book Value of Ugro Capital Ltd is 174.
What is the Dividend Yield of Ugro Capital Ltd?
The Dividend Yield of Ugro Capital Ltd is 0.00 %.
What is the ROCE of Ugro Capital Ltd?
The ROCE of Ugro Capital Ltd is 11.0 %.
What is the ROE of Ugro Capital Ltd?
The ROE of Ugro Capital Ltd is 8.26 %.
What is the Face Value of Ugro Capital Ltd?
The Face Value of Ugro Capital Ltd is 10.0.